Kathy Yi's most recent trade in Theseus Pharmaceuticals Inc was a trade of 19,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Theseus Pharmaceuticals Inc | Kathy Yi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Kathy Yi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 3,250 | 3,250 | - | - | Restricted Stock Unit | |
| Theseus Pharmaceuticals Inc | Kathy Yi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Kathy Yi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2021 | 22,678 | 22,678 | - | - | Stock Option (right to buy) | |
| Cerevel Therapeutics Holdings | Kathy Yi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 216,718 | 216,718 | - | - | Stock Option (Right to Buy) |